Cargando…
SARS-CoV-2-Seronegative Subjects Target CTL Epitopes in the SARS-CoV-2 Nucleoprotein Cross-Reactive to Common Cold Coronaviruses
The beta-coronavirus SARS-CoV-2 induces severe disease (COVID-19) mainly in elderly persons with risk factors, whereas the majority of patients experience a mild course of infection. As the circulating common cold coronaviruses OC43 and HKU1 share some homologous sequences with SARS-CoV-2, beta-coro...
Autores principales: | Schmidt, Katja G., Nganou-Makamdop, Krystelle, Tenbusch, Matthias, El Kenz, Boutaina, Maier, Clara, Lapuente, Dennis, Überla, Klaus, Spriewald, Bernd, Bergmann, Silke, Harrer, Ellen G., Harrer, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113865/ https://www.ncbi.nlm.nih.gov/pubmed/33995351 http://dx.doi.org/10.3389/fimmu.2021.627568 |
Ejemplares similares
-
Characterization of Serum and Mucosal SARS-CoV-2-Antibodies in HIV-1-Infected Subjects after BNT162b2 mRNA Vaccination or SARS-CoV-2 Infection
por: Schmidt, Katja G., et al.
Publicado: (2022) -
Definition of a New HLA B*52-Restricted Rev CTL Epitope Targeted by an HIV-1-Infected Controller
por: El Kenz, Boutaina, et al.
Publicado: (2023) -
Class switch towards non-inflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination
por: Irrgang, Pascal, et al.
Publicado: (2022) -
Ex Vivo Blockade of the PD-1 Pathway Improves Recall IFNγ Responses of HIV-Infected Persons on Antiretroviral Therapy
por: Fischhaber, Natalie, et al.
Publicado: (2023) -
Detection of pre-existing neutralizing antibodies against Ad26 in HIV-1-infected individuals not responding to the Ad26.COV2.S vaccine
por: Schmidt, Katja G., et al.
Publicado: (2023)